Companies / BSX vs SYK
BSX vs SYK: Boston Scientific and Stryker
Boston Scientific (BSX) reported $20.1B in revenue against a 14.4% net margin, while Stryker (SYK) reported $25.1B at a 12.9% net margin, most recently.
| Metric | BSX | SYK |
|---|---|---|
| Revenue | $20.1B | $25.1B |
| Net Income | $2.9B | $3.2B |
| Gross Margin | 69.0% | 64.0% |
| Operating Margin | 18.0% | 19.5% |
| EPS (Diluted) | $1.94 | $8.40 |
| Free Cash Flow | $3.7B | $4.3B |
| Total Debt | $11.4B | $15.9B |
| P/E Ratio | 49.2× | 41.8× |
| P/B Ratio | n/m | n/m |
| Stock Price | $44.62 | $335.11 |
Free: last 5 years
| Fiscal year | FY2007 🔒 | FY2008 🔒 | FY2009 🔒 | FY2010 🔒 | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2015 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BSX Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $11.9B | $12.7B | $14.2B | $16.7B | $20.1B |
| SYK Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $17.1B | $18.4B | $20.5B | $22.6B | $25.1B |